US4062932A
(en)
*
|
1975-03-10 |
1977-12-13 |
University Of Southern California |
Process for the catalytic oxidation of hydrogen sulfide with sulfur dioxide
|
DE2556561C2
(de)
*
|
1975-12-16 |
1983-04-14 |
Boehringer Mannheim Gmbh, 6800 Mannheim |
Verfahren zur Herstellung von porösen Tabletten
|
IE45770B1
(en)
*
|
1976-10-06 |
1982-11-17 |
Wyeth John & Brother Ltd |
Pharmaceutical dosage forms
|
GB1548022A
(en)
*
|
1976-10-06 |
1979-07-04 |
Wyeth John & Brother Ltd |
Pharmaceutial dosage forms
|
US4568547A
(en)
*
|
1979-08-30 |
1986-02-04 |
Herschler R J |
Solid pharmaceutical compositions comprising MSM and their production
|
US4883182A
(en)
*
|
1985-05-31 |
1989-11-28 |
Hughes Raymond J |
Tamper evident capsule and insert device
|
GB8624628D0
(en)
*
|
1986-10-14 |
1986-11-19 |
Scras |
Soluble/splitable tablets
|
WO1993012770A1
(en)
*
|
1991-12-20 |
1993-07-08 |
Pfizer Inc. |
Porous shaped delivery devices and method of producing thereof
|
WO1993013758A1
(en)
*
|
1992-01-13 |
1993-07-22 |
Pfizer Inc. |
Preparation of tablets of increased strength
|
HUT75616A
(en)
*
|
1992-03-17 |
1997-05-28 |
Pfizer |
Method for prooucing porous delivery devices
|
US6586006B2
(en)
|
1994-08-04 |
2003-07-01 |
Elan Drug Delivery Limited |
Solid delivery systems for controlled release of molecules incorporated therein and methods of making same
|
US6290991B1
(en)
|
1994-12-02 |
2001-09-18 |
Quandrant Holdings Cambridge Limited |
Solid dose delivery vehicle and methods of making same
|
WO1996008979A1
(en)
|
1994-09-22 |
1996-03-28 |
Quadrant Holdings Cambridge Limited |
Compositions for use in rehydration and nutrition during athletic exercise and methods of making same
|
US6964771B1
(en)
|
1995-06-07 |
2005-11-15 |
Elan Drug Delivery Limited |
Method for stably incorporating substances within dry, foamed glass matrices
|
US5762961A
(en)
*
|
1996-02-09 |
1998-06-09 |
Quadrant Holdings Cambridge Ltd. |
Rapidly soluble oral solid dosage forms, methods of making same, and compositions thereof
|
US5958455A
(en)
*
|
1996-02-09 |
1999-09-28 |
Quadrant Holdings Cambridge Ltd |
Oral solid dosage forms, methods of making same and compositions thereof
|
US6632648B1
(en)
|
1996-05-14 |
2003-10-14 |
Elan Drug Delivery Limited |
Methods of terminal sterilization of fibrinogen
|
KR100481583B1
(ko)
*
|
1996-06-14 |
2005-07-12 |
교와 핫꼬 고교 가부시끼가이샤 |
구강내에서빠르게붕괴하는정제
|
US8071128B2
(en)
|
1996-06-14 |
2011-12-06 |
Kyowa Hakko Kirin Co., Ltd. |
Intrabuccally rapidly disintegrating tablet and a production method of the tablets
|
AU733032C
(en)
*
|
1996-06-14 |
2002-01-03 |
Kyowa Hakko Kirin Co., Ltd. |
Intraorally rapidly disintegrable tablet
|
JP3152664B2
(ja)
|
1996-08-13 |
2001-04-03 |
協和醗酵工業株式会社 |
同位体尿素の錠剤
|
US6468782B1
(en)
|
1996-12-05 |
2002-10-22 |
Quadrant Healthcare (Uk) Limited |
Methods of preserving prokaryotic cells and compositions obtained thereby
|
US20040023948A1
(en)
*
|
1997-03-24 |
2004-02-05 |
Green Richard David |
Fast-dispersing dosage form containing 5-HT1 agonists
|
US20060165606A1
(en)
|
1997-09-29 |
2006-07-27 |
Nektar Therapeutics |
Pulmonary delivery particles comprising water insoluble or crystalline active agents
|
US6565885B1
(en)
|
1997-09-29 |
2003-05-20 |
Inhale Therapeutic Systems, Inc. |
Methods of spray drying pharmaceutical compositions
|
GT199900061A
(es)
*
|
1998-05-15 |
2000-10-14 |
Pfizer |
Formulaciones farmaceuticas.
|
CN1329487A
(zh)
|
1998-11-10 |
2002-01-02 |
特瓦制药工业有限公司 |
包含l-多巴乙酯的可分散组合物
|
GB9908014D0
(en)
|
1999-04-08 |
1999-06-02 |
Scherer Corp R P |
Pharmaceutical compositions
|
US6284270B1
(en)
|
1999-08-04 |
2001-09-04 |
Drugtech Corporation |
Means for creating a mass having structural integrity
|
US8404217B2
(en)
|
2000-05-10 |
2013-03-26 |
Novartis Ag |
Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
|
US7871598B1
(en)
|
2000-05-10 |
2011-01-18 |
Novartis Ag |
Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
|
DK1280520T4
(en)
|
2000-05-10 |
2018-06-25 |
Novartis Ag |
Phospholipid based powders for drug delivery
|
US20020001617A1
(en)
*
|
2000-05-26 |
2002-01-03 |
Chang-Hyun Lee |
Rapidly disintegrating tablet and process for the manufacture thereof
|
US20030185886A1
(en)
*
|
2000-05-26 |
2003-10-02 |
Hanmi Pharm. Co., Ltd. |
Process for the preparation of rapidly disintegrating tablet
|
GB0028709D0
(en)
*
|
2000-11-24 |
2001-01-10 |
S P A |
Process
|
US6544552B2
(en)
*
|
2001-01-11 |
2003-04-08 |
Particle And Coating Technologies, Inc. |
Method of producing porous tablets with improved dissolution properties
|
IL157320A0
(en)
*
|
2001-02-08 |
2004-02-19 |
Pharmacia Corp |
Rapid-onset medicament for the treatment of sexual dysfunction
|
KR20030081472A
(ko)
*
|
2001-03-06 |
2003-10-17 |
교와 핫꼬 고교 가부시끼가이샤 |
구강내 속붕괴성 제제
|
US6509040B1
(en)
|
2001-06-22 |
2003-01-21 |
R.P. Scherer Corporation |
Fast dispersing dosage forms essentially free of mammalian gelatin
|
US9358214B2
(en)
*
|
2001-10-04 |
2016-06-07 |
Adare Pharmaceuticals, Inc. |
Timed, sustained release systems for propranolol
|
WO2003053411A1
(en)
|
2001-12-19 |
2003-07-03 |
Nektar Therapeutics |
Pulmonary delivery of aminoglycosides
|
EP2085074A1
(en)
*
|
2002-03-26 |
2009-08-05 |
Teva Pharmaceutical Industries Ltd. |
Drug microparticles
|
BR0314525A
(pt)
*
|
2002-10-04 |
2005-07-26 |
Pharmacia Corp |
Composições e métodos para tratamento de disfunção sexual
|
BR0315731A
(pt)
*
|
2002-10-30 |
2005-09-06 |
Pharmacia Corp |
Comprimidos orais de liberação prolongada e métodos para fabricar e usar os mesmos
|
US8367111B2
(en)
*
|
2002-12-31 |
2013-02-05 |
Aptalis Pharmatech, Inc. |
Extended release dosage forms of propranolol hydrochloride
|
EP1620075B1
(en)
*
|
2003-05-07 |
2020-06-24 |
Samyang Biopharmaceuticals Corporation |
Highly plastic granules for making fast melting tablets
|
US7390503B1
(en)
|
2003-08-22 |
2008-06-24 |
Barr Laboratories, Inc. |
Ondansetron orally disintegrating tablets
|
US8747895B2
(en)
*
|
2004-09-13 |
2014-06-10 |
Aptalis Pharmatech, Inc. |
Orally disintegrating tablets of atomoxetine
|
US9884014B2
(en)
|
2004-10-12 |
2018-02-06 |
Adare Pharmaceuticals, Inc. |
Taste-masked pharmaceutical compositions
|
ES2409347T3
(es)
|
2004-10-21 |
2013-06-26 |
Aptalis Pharmatech, Inc. |
Composiciones farmacéuticas de sabor enmascarado con agentes porogénicos gastrosolubles
|
CN102631289B
(zh)
*
|
2004-10-28 |
2016-05-04 |
潘特克股份公司 |
高孔隙度的速崩固体剂型及其包括生产粉末和冻干步骤的制备方法
|
US20060105038A1
(en)
*
|
2004-11-12 |
2006-05-18 |
Eurand Pharmaceuticals Limited |
Taste-masked pharmaceutical compositions prepared by coacervation
|
US9161918B2
(en)
|
2005-05-02 |
2015-10-20 |
Adare Pharmaceuticals, Inc. |
Timed, pulsatile release systems
|
GB0516604D0
(en)
*
|
2005-08-12 |
2005-09-21 |
Sandoz Ag |
Rapidly dispersing/disintegrating compositions
|
US20090068262A1
(en)
*
|
2007-04-04 |
2009-03-12 |
Ilan Zalit |
Rapid dissolution of combination products
|
EP2170282A4
(en)
*
|
2007-06-27 |
2014-11-05 |
Hanmi Pharm Ind Co Ltd |
METHOD FOR PREPARING RAPID DISAGGREGATION FORMULATION FOR ORAL ADMINISTRATION AND APPARATUS FOR PREPARING AND PACKAGING THEREFOR
|
US20090060983A1
(en)
*
|
2007-08-30 |
2009-03-05 |
Bunick Frank J |
Method And Composition For Making An Orally Disintegrating Dosage Form
|
CA2704209C
(en)
*
|
2007-10-31 |
2017-02-28 |
Mcneil-Ppc, Inc. |
Orally disintegrative dosage form
|
WO2011004799A1
(ja)
*
|
2009-07-06 |
2011-01-13 |
杏林製薬株式会社 |
中空構造を有する錠剤
|
US8313768B2
(en)
|
2009-09-24 |
2012-11-20 |
Mcneil-Ppc, Inc. |
Manufacture of tablet having immediate release region and sustained release region
|
US20110070286A1
(en)
*
|
2009-09-24 |
2011-03-24 |
Andreas Hugerth |
Process for the manufacture of nicotine-comprising chewing gum and nicotine-comprising chewing gum manufactured according to said process
|
US8784781B2
(en)
*
|
2009-09-24 |
2014-07-22 |
Mcneil-Ppc, Inc. |
Manufacture of chewing gum product with radiofrequency
|
US8858210B2
(en)
|
2009-09-24 |
2014-10-14 |
Mcneil-Ppc, Inc. |
Manufacture of variable density dosage forms utilizing radiofrequency energy
|
JP5309262B2
(ja)
|
2009-12-02 |
2013-10-09 |
アプタリス ファーマ リミテッド |
フェキソフェナジン・マイクロカプセル及びそれを含む組成物
|
WO2011085181A1
(en)
*
|
2010-01-08 |
2011-07-14 |
Eurand, Inc. |
Taste masked topiramate composition and an orally disintegrating tablet comprising the same
|
US9511028B2
(en)
|
2012-05-01 |
2016-12-06 |
Johnson & Johnson Consumer Inc. |
Orally disintegrating tablet
|
US9445971B2
(en)
|
2012-05-01 |
2016-09-20 |
Johnson & Johnson Consumer Inc. |
Method of manufacturing solid dosage form
|
US9233491B2
(en)
|
2012-05-01 |
2016-01-12 |
Johnson & Johnson Consumer Inc. |
Machine for production of solid dosage forms
|
RU2712267C2
(ru)
|
2014-01-10 |
2020-01-28 |
Джонсон энд Джонсон Консьюмер Инк. |
Способ изготовления таблеток с использованием радиочастотного излучения и частиц с поглощающим покрытием
|
KR102392347B1
(ko)
|
2016-04-21 |
2022-05-02 |
아스트라제네카 아베 |
경구 붕해 정제
|
US10493026B2
(en)
|
2017-03-20 |
2019-12-03 |
Johnson & Johnson Consumer Inc. |
Process for making tablet using radiofrequency and lossy coated particles
|